Key result
Subcutaneous PPARA and LEPR expression identifies metabolic syndrome in severely obese women with ~0.87 AUC.
Why the study?
Metabolic syndrome is a cluster of major heart attack risk factors, but differences in obesity-associated white adipose tissue dysfunction between severely obese individuals with or without it require comparison.
Does the presence of metabolic syndrome alter adipose tissue morphology and gene expression in severely obese women?
Observational (n=66)
Does the presence of metabolic syndrome alter adipose tissue morphology and gene expression in severely obese women?
Severely obese women with metabolic syndrome exhibit distinct morphological and transcriptional differences in adipose tissue, particularly subcutaneous fat, which may drive the transition to metabolic syndrome.
Answers are grounded in this paper and cite their sources.
Adipose changes associate with metabolic syndrome in severe obesity; hypothesis-generating for PPARA/LEPR biomarkers pending validation.
The metabolic syndrome (MetS) is a cluster of the most dangerous heart attack risk factors: diabetes or raised fasting plasma glucose, abdominal obesity, high cholesterol and high blood pressure. The goal of this study is to compare the state of the main features of obesity-associated white adipose tissue (WAT) dysfunction in 66 women with severe obesity without (MetS−) or with MetS (MetS+). Fat cell area, adipocyte size distribution and histological fibrosis were analysed in visceral (VAT) and abdominal subcutaneous WAT (SAT) in 33 age- and BMI-matched pairs of MetS− and MetS+ subjects. The mRNA expression of 93 genes implicated in obesity-associated WAT dysfunction was analysed by RT-qPCR in both fat depots. MetS+ females showed higher adipocyte hypertrophy in both fat depots and increased fibrosis and expression of macrophage and hypoxia markers in SAT. Transcriptional data suggest increased fatty acid oxidation in SAT and impaired thermogenesis and extracellular matrix remodelling in VAT from MetS+ subjects. A sPLS-DA model, including SAT expression of PPARA and LEPR genes identified MetS with an AUC = 0.87. Despite equal age, BMI and body composition, MetS+ females display morphological and transcriptional differences in both WAT depots, especially in SAT. These factors may contribute to the transition to MetS.
No takes yet. Share an insight, caveat, or question.
Osorio-Conles et al. (2022) conducted an observational in Severe obesity (n=66). Metabolic syndrome vs. No metabolic syndrome was evaluated on White adipose tissue dysfunction features and identification of metabolic syndrome (AUC 0.87). Severely obese women with metabolic syndrome displayed greater adipocyte hypertrophy and fibrosis, with subcutaneous expression of PPARA and LEPR genes identifying the syndrome with an AUC of 0.87.
Synapse has enriched 10 related papers. Consider them for comparative context: